NURYLBO

Serial Number 88579099
606

Registration Progress

Application Filed
Aug 14, 2019
Under Examination
Feb 18, 2020
Approved for Publication
Dec 24, 2019
Published for Opposition
Dec 24, 2019
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: NURYLBO
Previous Owner: Ovid Therapeutics Inc.
Classes: 005

Trademark Image

NURYLBO

Basic Information

Serial Number
88579099
Filing Date
August 14, 2019
Published for Opposition
December 24, 2019
Abandonment Date
March 27, 2023
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Mar 27, 2023
Classes
005

Rights Holder

Ovid Therapeutics Inc.

03
Address
1460 Broadway
New York, NY 10036

Ownership History

Ovid Therapeutics Inc.

Original Applicant
03
New York, NY

Ovid Therapeutics Inc.

Owner at Publication
03
New York, NY

Legal Representation

Attorney
Jeffrey S.Steen

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

31 events
Date Code Type Description Documents
Mar 27, 2023 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Mar 27, 2023 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Aug 20, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 19, 2022 EX5G S SOU EXTENSION 5 GRANTED Loading...
Aug 8, 2022 EXT5 S SOU EXTENSION 5 FILED Loading...
Aug 16, 2022 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Aug 8, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 9, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 7, 2022 EX4G S SOU EXTENSION 4 GRANTED Loading...
Feb 7, 2022 EXT4 S SOU EXTENSION 4 FILED Loading...
Feb 7, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 14, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 12, 2021 EX3G S SOU EXTENSION 3 GRANTED Loading...
Aug 12, 2021 EXT3 S SOU EXTENSION 3 FILED Loading...
Aug 12, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 13, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 11, 2021 EX2G S SOU EXTENSION 2 GRANTED Loading...
Feb 11, 2021 EXT2 S SOU EXTENSION 2 FILED Loading...
Feb 11, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 12, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 10, 2020 EX1G S SOU EXTENSION 1 GRANTED Loading...
Aug 10, 2020 EXT1 S SOU EXTENSION 1 FILED Loading...
Aug 10, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 18, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Dec 24, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 24, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 4, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 18, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 13, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 29, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 17, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of developmental disorders; Pharmaceutical preparations for the treatment of neurological disorders

Classification

International Classes
005